comprehensive -WSS

comprehensive

author：leisure time 2025-10-02 22:24:45 - browse：4383

Black and white illustrated portrait of Mark Parrino — Mark Parrino: "I don’t think the dominant interest is just giving lots more take-homes to patients. There’s more to treatment than that." Molly Ferguson for STAT

Nobody has made more of an impact on methadone treatment than Mark Parrino.

For decades, he’s served as the founder and president of the American Association for the Treatment of Opioid Dependence, a nationwide advocacy group representing methadone clinics. Before AATOD, he ran a statewide advocacy group in New York, having made the jump to politics and policy after working as a clinic director and, before that, as an addiction counselor.

Now, a half-century after he began his career in addiction treatment, Parrino is facing what is perhaps a career-defining fight. In the last few years alone, the nation’s tone on opioid treatment programs (OTPs), as they are known, has shifted significantly. While methadone has long been stigmatized, a growing coalition of advocates, lawmakers, and addiction doctors is now pushing to significantly deregulate methadone treatment — and in particular, to offer it outside the context of the specialized clinics that Parrino has long represented.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Heart disease in astronauts blamed on cosmic radiation

WSS

John Green on his newest strategy for fighting tuberculosis

Flint parents haunted by uncertainty, fears of lead poisoning

EPA limits use of carcinogenic gas for sterilizing medical devices

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Chris Christie meets with Zelenskyy during Ukraine trip

Steward Health Care Massachusetts hospitals face fiscal disaster

knowledge

comprehensive

knowledge

Heart attack and stroke risk calculators need revising

Amid AI frenzy, a top HHS official's quest to create safeguards

Jerome Adams on the need for new antivirals for Covid

Personalized medicine goes far beyond genetics

Apple is now the first public company to be valued at $3 trillion

RaDonda Vaught links Vanderbilt hospital issues to patient death

Tori Bowie and the unacceptable rates of Black maternal death

How to save health care price transparency rules

Moonlake's readout produced a cash windfall. Risks remain

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

focus

H.R. 3 is the wrong path to lower drug costs

FDA scientists endorse Pfizer/BioNTech Covid

As AI in medicine takes off, can 'human in the loop' prevent harm?

WuXi out of biotech trade group, U.S. and China relations to blame

Boston's new lab space is opening empty

Boston's new lab space is opening empty

leisure time

Wikipedia

hotspot

focus